glp 1 and colonoscopy Quality of bowel preparation for in patients on glucagon-like peptide-1 receptor agonists GLP-1 Medicines And Gut Bacterial

Food and Drug Administration has recently identified drug-induced alopecia (hair loss) as an adverse event for patients taking GLP-1 medications

WeightWatchers operates at a more moderate calorie deficit with better long-term sustainability research

Inhibition of DPP4 activity by synthetic inhibitors, such as those used to treat type 2 diabetes, results in suppression of T cell proliferation in vitro and a decrease in antibody production in vivo

Ethical approval was not required as the study was conducted using de-identified publicly available data

Dose selection and dose escalation must be managed by a licensed healthcare provider